New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquim Gascón, Fabiana Barreira, Bethania Blum, Igor C. Almeida, Cristina Alonso-Vega, Tayná Barboza, Graeme Bilbe, Erika Correia, Wilson Garcia, Lourdes Ortiz, Rudy Parrado, Juan Carlos Ramirez, Isabela Ribeiro, Nathalie Strub-Wourgaft, Michel Vaillant, Sergio Sosa-Estani*, Roger Arteaga, Anabelle de la Barra, Jhonny Camacho BorjaIvana Martinez, Jayme Fernandes, Lineth Garcia, Daniel Lozano, Alejandro Palacios, Alejandro Schijman, Maria Jesus Pinazo, Jimmy Pinto, Gimena Rojas, Igor Estevao, Uriel Ortega-Rodriguez, Maria Tays Mendes, Edgar Schuck, Katsura Hata, Noritsugu Maki, Makoto Asada, BENDITA study group

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

73 Citations (Scopus)

Fingerprint

Dive into the research topics of 'New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science